Skip to content

Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Arena Pharmaceuticals, Inc. Announces Completion of Acquisition Of Bunsen Rush Laboratories, Inc
Arena Pharmaceuticals, Inc. Announces Completion of Acquisition Of Bunsen Rush Laboratories, Inc SAN DIEGO, Feb. 20 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) ("Arena") today announced the completion of the acquisition of the outstanding capital stock of Bunsen Rush Laboratories,
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Announces Licensing of 'Obesity' Orphan Receptor Target and Small Molecule Modulators
Arena Pharmaceuticals, Inc. Announces Licensing of 'Obesity' Orphan Receptor Target and Small Molecule Modulators SAN DIEGO, Jan. 31 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) ("Arena") today announced the signing of an expansion amendment to its May 29, 2000 research agreement with
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Announces Receipt of Second Milestone Payments From Eli Lilly and Company
Arena Pharmaceuticals, Inc. Announces Receipt of Second Milestone Payments From Eli Lilly and Company SAN DIEGO, Jan. 15 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that under the terms of its April 14, 2000 research collaboration and license agreement with Eli Lilly
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. and Bunsen Rush Laboratories, Inc. Jointly Announce Signing of Letter of Intent & Memorandum of Agreement
Arena Pharmaceuticals, Inc. and Bunsen Rush Laboratories, Inc. Jointly Announce Signing of Letter of Intent & Memorandum of Agreement SAN DIEGO and DALLAS, Dec. 27 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) ("Arena") and Bunsen Rush Laboratories, Inc.
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Announces Issuance of Notice of Allowance for Drug Discovery Using First Cart-Activated Receptor
Arena Pharmaceuticals, Inc. Announces Issuance of Notice of Allowance for Drug Discovery Using First Cart-Activated Receptor SAN DIEGO, Nov. 29 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced the issuance of a Notice of Allowance ("Allowance") from the United States
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Announces Achievement Of CART Milestones With Taisho Pharmaceutical Co., Ltd
Arena Pharmaceuticals, Inc. Announces Achievement Of CART Milestones With Taisho Pharmaceutical Co., Ltd SAN DIEGO, Oct. 23 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that under the terms of its May 29, 2000 research agreement with Taisho Pharmaceutical Co., Ltd.,
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Announces Receipt of First CART Milestone Payments From Eli Lilly and Company
Arena Pharmaceuticals, Inc. Announces Receipt of First CART Milestone Payments From Eli Lilly and Company SAN DIEGO, Sept. 25 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that under the terms of its April 14, 2000 research collaboration and license agreement with Eli
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Announces Grant of First U.S. Patent; Method Claims Directed to CART-Discovered Inverse Agonist Compounds
Arena Pharmaceuticals, Inc. Announces Grant of First U.S. Patent; Method Claims Directed to CART-Discovered Inverse Agonist Compounds SAN DIEGO, Aug. 22 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced the issuance of United States Patent Number 6,107,324 entitled
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Announces Exercise of Over-Allotment Option
Arena Pharmaceuticals, Inc. Announces Exercise of Over-Allotment Option SAN DIEGO, Aug. 10 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the underwriters led by ING Barings LLC, Prudential Securities Incorporated, and SG Cowen Securities Corporation, have exercised
View HTML
Toggle Summary Lexicon Genetics and Arena Pharmaceuticals Target New Receptors for Pharmaceutical Development
-- In vivo Screens Detect Modulators of G-Protein Coupled Receptor Activity
View HTML